Skip to main content
SpringerLink
Log in

Etiology of Cancer-Induced Male Infertility

  • Chapter
  • First Online:
The Complete Guide to Male Fertility Preservation

Abstract

Male fertility can be temporarily or permanently affected by cancer in various ways. The disease process as well as treatments of cancer can impair the hypothalamic-pituitary-gonadal axis, the structural and functional integrity of the germinal epithelium, and male sexual function. This chapter discusses how cancer in males of reproductive age can cause or worsen male factor infertility through its pre-testicular, testicular, and post-testicular components.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. de Bruin D, de Jong IJ, Arts EG, Nuver J, Dullaart RP, et al. Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones. Fertil Steril. 2009;91:2481–6.

    Article  PubMed  Google Scholar 

  2. Hansen PV, Trykker H, Andersen J, Helkjaer PE. Germ cell function and hormonal status in patients with testicular cancer. Cancer. 1989;64:956–61.

    Article  CAS  PubMed  Google Scholar 

  3. Choy JT, Wiser HJ, Bell SW, Cashy J, Brannigan RE, et al. Predictors of spermatogenesis in orchiectomy specimens. Urology. 2013;81:288–92.

    Article  PubMed  Google Scholar 

  4. El-Sakka AI, Hassoba HM, Sayed HM, Tayeb KA. Pattern of endocrinal changes in patients with sexual dysfunction. J Sex Med. 2005;2:551–8.

    Article  CAS  PubMed  Google Scholar 

  5. Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:2330–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ratnasingam J, Karim N, Paramasivam SS, Ibrahim L, Lim LL, et al. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors. Pituitary. 2014;18:1–8.

    Google Scholar 

  7. Agha A, Sherlock M, Brennan S, O’Connor SA, O’Sullivan E, et al. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab. 2005;90:6355–60.

    Article  CAS  PubMed  Google Scholar 

  8. Coviello AD, Bremner WJ, Matsumoto AM, Herbst KL, Amory JK, et al. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. J Androl. 2004;25:931–8.

    Article  CAS  PubMed  Google Scholar 

  9. O’Shaughnessy PJ, Verhoeven G, De Gendt K, Monteiro A, Abel MH. Direct action through the Sertoli cells is essential for androgen stimulation of spermatogenesis. Endocrinology. 2010;151:2343–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Verhoeven G, Cailleau J. Follicle-stimulating hormone and androgens increase the concentration of the androgen receptor in Sertoli cells. Endocrinology. 1988;122:1541–50.

    Article  CAS  PubMed  Google Scholar 

  11. De Gendt K, Swinnen JV, Saunders PT, Schoonjans L, Dewerchin M, et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc Natl Acad Sci U S A. 2004;101:1327–32.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Verhoeven G. A Sertoli cell-specific knock-out of the androgen receptor. Andrologia. 2005;37:207–8.

    Article  CAS  PubMed  Google Scholar 

  13. Tan KA, De Gendt K, Atanassova N, Walker M, Sharpe RM, et al. The role of androgens in Sertoli cell proliferation and functional maturation: studies in mice with total or Sertoli cell-selective ablation of the androgen receptor. Endocrinology. 2005;146:2674–83.

    Article  CAS  PubMed  Google Scholar 

  14. Strumberg D, Brugge S, Korn MW, Koeppen S, Ranft J, et al. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol. 2002;13:229–36.

    Article  CAS  PubMed  Google Scholar 

  15. Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol. 1996;14:2923–32.

    Article  CAS  PubMed  Google Scholar 

  16. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, et al. The effects of Hodgkin’s disease and combination chemotherapy on gonadal function in the adult male. Cancer. 1982;49:418–22.

    Article  CAS  PubMed  Google Scholar 

  17. van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, et al. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin’s lymphoma with chemotherapy during childhood. Hum Reprod. 2007;22:3215–22.

    Article  PubMed  Google Scholar 

  18. Orth JM, Gunsalus GL, Lamperti AA. Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development. Endocrinology. 1988;122:787–94.

    Article  CAS  PubMed  Google Scholar 

  19. Hinrichsen MJ, Blaquier JA. Evidence supporting the existence of sperm maturation in the human epididymis. J Reprod Fertil. 1980;60:291–4.

    Article  CAS  PubMed  Google Scholar 

  20. Wilkerson ML, Bartone FF, Fox L, Hadziselimovic F. Fertility potential: a comparison of intra-abdominal and intracanalicular testes by age groups in children. Horm Res. 2001;55:18–20.

    CAS  PubMed  Google Scholar 

  21. Engeler DS, Hosli PO, John H, Bannwart F, Sulser T, et al. Early orchiopexy: prepubertal intratubular germ cell neoplasia and fertility outcome. Urology. 2000;56:144–8.

    Article  CAS  PubMed  Google Scholar 

  22. Lip SZL, Murchison LED, Cullis PS, Govan L, Carachi R. A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child. 2013;98:20–6.

    Article  PubMed  Google Scholar 

  23. Herrinton LJ, Zhao W, Husson G. Management of cryptorchidism and risk of testicular cancer. Am J Epidemiol. 2003;157:602–5.

    Article  PubMed  Google Scholar 

  24. Walsh TJ, Dall’Era MA, Croughan MS, Carroll PR, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol. 2007;178:1440–6.

    Article  PubMed  Google Scholar 

  25. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007;356:1835–41.

    Article  CAS  PubMed  Google Scholar 

  26. Mancini M, Carmignani L, Gazzano G, Sagone P, Gadda F, et al. High prevalence of testicular cancer in azoospermic men without spermatogenesis. Hum Reprod. 2007;22:1042–6.

    Article  CAS  PubMed  Google Scholar 

  27. Skakkebaek NS, Holm M, Hoei-Hansen C, Jorgensen N, Rajpert-de ME. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS. 2003;111:1–11.

    Article  PubMed  Google Scholar 

  28. Lackner JE, Koller A, Schatzl G, Marberger M, Kratzik C. Does histopathologic tumor type or vascular invasion influence spermatogenesis in testicular cancer? Fertil Steril. 2007;88:1377–81.

    Article  CAS  PubMed  Google Scholar 

  29. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol. 2003;200:370–4.

    Article  PubMed  Google Scholar 

  30. Condorelli R, Calogero AE, La Vignera S. Relationship between testicular volume and conventional or nonconventional sperm parameters. Int J Endocrinol. 2013;2013:1–6.

    Article  Google Scholar 

  31. Petersen PM, Skakkebaek NE, Rorth M, Giwercman A. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J Urol. 1999;161:822–6.

    Article  CAS  PubMed  Google Scholar 

  32. Selice R, Ferlin A, Garolla A, Caretta N, Foresta C. Effects of endogenous FSH on normal human spermatogenesis in adults. Int J Androl. 2011;34:511–7.

    Article  Google Scholar 

  33. Liguori G, Trombetta C, Bucci S, Benvenuto S, Amodeo A, et al. Semen quality before and after orchiectomy in men with testicular cancer. Arch Ital Urol Androl. 2008;80:99–102.

    PubMed  Google Scholar 

  34. Rives N, Perdrix A, Hennebicq S, Saias-Magnan J, Melin MC, et al. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network. J Androl. 2012;33:1394–401.

    Article  PubMed  Google Scholar 

  35. Carlsen E, Andersson AM, Petersen JH, Skakkebaek NE. History of febrile illness and variation in semen quality. Hum Reprod. 2003;18:2089–92.

    Article  PubMed  Google Scholar 

  36. Sergerie M, Mieusset R, Croute F, Daudin M, Bujan L. High risk of temporary alteration of semen parameters after recent acute febrile illness. Fertil Steril. 2007;88:971–7.

    Article  Google Scholar 

  37. van der Kaaij MA, Heutte N, van Echten-Arends J, Raemaekers JM, Carde P, et al. Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica. 2009;94:1691–7.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Marmor D, Elefant E, Dauchez C, Roux C. Semen analysis in Hodgkin’s disease before the onset of treatment. Cancer. 1986;57:1986–7.

    Article  CAS  PubMed  Google Scholar 

  39. Mazzu D, Jeffrey RB Jr, Ralls PW. Lymphoma and leukemia involving the testicles: findings on gray-scale and color Doppler sonography. AJR Am J Roentgenol. 1995;164:645–7.

    Article  CAS  PubMed  Google Scholar 

  40. Garolla A, Torino M, Miola P, Caretta N, Pizzol D, et al. Twenty-four-hour monitoring of scrotal temperature in obese men and men with a varicocele as a mirror of spermatogenic function. Hum Reprod. 2015;30:1006–13.

    Article  CAS  PubMed  Google Scholar 

  41. Chen SS, Chen LK. Risk factors for progressive deterioration of semen quality in patients with varicocele. Urology. 2012;79:128–32.

    Article  PubMed  Google Scholar 

  42. Hosseinifar H, Sabbaghian M, Nasrabadi D, Modarresi T, Dizaj AV, et al. Study of the effect of varicocelectomy on sperm proteins expression in patients with varicocele and poor sperm quality by using two-dimensional gel electrophoresis. J Assist Reprod Genet. 2014;31:725–9.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Ho GT, Gardner H, DeWolf WC, Loughlin KR, Morgentaler A. Influence of testicular carcinoma on ipsilateral spermatogenesis. J Urol. 1992;148:821–5.

    Article  CAS  PubMed  Google Scholar 

  44. Ho GT, Gardner H, Mostofi K, DeWolf WC, Loughlin KR, et al. The effect of testicular nongerm cell tumors on local spermatogenesis. Fertil Steril. 1994;62:162–6.

    Article  CAS  PubMed  Google Scholar 

  45. Fraietta R, Spaine DM, Bertolla RP, Ortiz V, Cedenho AP. Individual and seminal characteristics of patients with testicular germ cell tumors. Fertil Steril. 2010;94:2107–12.

    Article  PubMed  Google Scholar 

  46. Fitoussi O, Eghbali H, Tchen N, Berjon JP, Soubeyran P, et al. Semen analysis and cryoconservation before treatment in Hodgkin’s disease. Ann Oncol. 2000;11:679–84.

    Article  CAS  PubMed  Google Scholar 

  47. Redman JR, Bajorunas DR, Goldstein MC, Evenson DP, Gralla RJ, et al. Semen cryopreservation and artificial insemination for Hodgkin’s disease. J Clin Oncol. 1987;5:233–8.

    Article  CAS  PubMed  Google Scholar 

  48. Hallak J, Mahran AM, Agarwal A. Characteristics of cryopreserved semen from men with lymphoma. J Assist Reprod Genet. 2000;17:591–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, et al. Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol. 2001;12:1307–11.

    Article  CAS  PubMed  Google Scholar 

  50. Hallak J, Kolettis PN, Sekhon VS, Thomas AJ Jr, Agarwal A. Cryopreservation of sperm from patients with leukemia: is it worth the effort? Cancer. 1999;85:1973–8.

    Article  CAS  PubMed  Google Scholar 

  51. Botchan A, Hauser R, Gamzu R, Yogev L, Lessing JB, et al. Sperm quality in Hodgkin’s disease versus non-Hodgkin’s lymphoma. Hum Reprod. 1997;12:73–6.

    Article  CAS  PubMed  Google Scholar 

  52. Di Bisceglie C, Bertagna A, Composto ER, Lanfranco F, Baldi M, et al. Effects of oncological treatments on semen quality in patients with testicular neoplasia or lymphoproliferative disorders. Asian J Androl. 2013;15:425–9.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Gandini L, Sgro P, Lombardo F, Paoli D, Culasso F, et al. Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients. Hum Reprod. 2006;21:2882–9.

    Article  CAS  PubMed  Google Scholar 

  54. Bujan L, Walschaerts M, Brugnon F, Daudin M, Berthaut I, et al. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network. Fertil Steril. 2014;102:667–674.e663.

    Article  CAS  PubMed  Google Scholar 

  55. Kobayashi H, Urashima M, Hoshi Y, Uchiyama H, Fujisawa K, et al. Testicular morphological changes in children with acute lymphoblastic leukemia following chemotherapy. Acta Paediatr Jpn. 1996;38:640–3.

    Article  CAS  PubMed  Google Scholar 

  56. Tal R, Botchan A, Hauser R, Yogev L, Paz G, et al. Follow-up of sperm concentration and motility in patients with lymphoma. Hum Reprod. 2000;15:1985–8.

    Article  CAS  PubMed  Google Scholar 

  57. Wallace WH, Shalet SM, Lendon M, Morris-Jones PH. Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. Int J Androl. 1991;14:312–9.

    Article  CAS  PubMed  Google Scholar 

  58. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA. 1988;259:2123–5.

    Article  CAS  PubMed  Google Scholar 

  59. Bokemeyer C, Schmoll HJ, van Rhee J, Kuczyk M, Schuppert F, et al. Long-term gonadal toxicity after therapy for Hodgkin’s and non-Hodgkin’s lymphoma. Ann Hematol. 1994;68:105–10.

    Article  CAS  PubMed  Google Scholar 

  60. Brydoy M, Fossa SD, Klepp O, Bremnes RM, Wist EA, et al. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol. 2010;58:134–40.

    Article  PubMed  Google Scholar 

  61. Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001;91:613–21.

    Article  CAS  PubMed  Google Scholar 

  62. Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol. 2014;15:1215–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Romerius P, Stahl O, Moell C, Relander T, Cavallin-Stahl E, et al. High risk of azoospermia in men treated for childhood cancer. Int J Androl. 2011;34:69–76.

    Article  CAS  PubMed  Google Scholar 

  64. Bujan L, Walschaerts M, Moinard N, Hennebicq S, Saias J, et al. Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network. Fertil Steril. 2013;100:673–80.

    Article  CAS  PubMed  Google Scholar 

  65. Kinsella TJ, Trivette G, Rowland J, Sorace R, Miller R, et al. Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin’s disease. J Clin Oncol. 1989;7:718–24.

    Article  CAS  PubMed  Google Scholar 

  66. Hansen PV, Trykker H, Svennekjaer IL, Hvolby J. Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer. Radiother Oncol. 1990;18:117–25.

    Article  CAS  PubMed  Google Scholar 

  67. Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15:608–13.

    CAS  PubMed  Google Scholar 

  68. Hahn EW, Feingold SM, Nisce L. Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: a progress report. Radiology. 1976;119:223–5.

    Article  CAS  PubMed  Google Scholar 

  69. Speiser B, Rubin P, Casarett G. Aspermia following lower truncal irradiation in Hodgkin’s disease. Cancer. 1973;32:692–8.

    Article  CAS  PubMed  Google Scholar 

  70. Nalesnik JG, Sabanegh ES Jr, Eng TY, Buchholz TA. Fertility in men after treatment for stage 1 and 2A seminoma. Am J Clin Oncol. 2004;27:584–8.

    Article  PubMed  Google Scholar 

  71. Bahadur G, Ozturk O, Muneer A, Wafa R, Ashraf A, et al. Semen quality before and after gonadotoxic treatment. Hum Reprod. 2005;20:774–81.

    Article  CAS  PubMed  Google Scholar 

  72. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace H, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.

    Article  PubMed  Google Scholar 

  73. Hartmann JT, Albrecht C, Schmoll HJ, Kuczyk MA, Kollmannsberger C, et al. Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer. 1999;80:801–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Dimitropoulos K, Karatzas A, Papandreou C, Daliani D, Zachos I, et al. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders. Andrologia. 2016;48:425–30.

    Article  CAS  PubMed  Google Scholar 

  75. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 2000;55:58–61.

    Article  CAS  PubMed  Google Scholar 

  76. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer. JAMA. 2000;283:354–60.

    Article  CAS  PubMed  Google Scholar 

  77. Kyo K, Sameshima S, Takahashi M, Furugori T, Sawada T. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg. 2006;30:1014–9.

    Article  PubMed  Google Scholar 

  78. Akasu T, Sugihara K, Moriya Y. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol. 2009;16:2779–86.

    Article  PubMed  Google Scholar 

  79. Lange MM, Marijnen CAM, Maas CP, Putter H, Rutten HJ, et al. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer. 2009;45:1578–88.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Loma Linda University Health, Loma Linda, CA, USA

    Julie Won-Ching Cheng MD, MAE & Edmund Y. Ko MD

Authors
  1. Julie Won-Ching Cheng MD, MAE
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edmund Y. Ko MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Won-Ching Cheng MD, MAE .

Editor information

Editors and Affiliations

  1. Department of Urology, Hamad Medical Corporation, Doha, Qatar

    Ahmad Majzoub

  2. Department of Urology, Andrology Center, Cleveland Clinic, Cleveland, Ohio, USA

    Ashok Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cheng, J.WC., Ko, E.Y. (2018). Etiology of Cancer-Induced Male Infertility. In: Majzoub, A., Agarwal, A. (eds) The Complete Guide to Male Fertility Preservation. Springer, Cham. https://doi.org/10.1007/978-3-319-42396-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42396-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42395-1

  • Online ISBN: 978-3-319-42396-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation